A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface.
Light chain amyloidosis is a devastating protein misfolding disease characterized by the accumulation of amyloid fibrils that causes tissue damage and organ failure. These fibrils are composed of monoclonal light chain protein secreted from an abnormal proliferation of bone marrow plasma cells. We previously reported that amyloidogenic light chain protein AL-09 adopts an altered dimer while its germline protein (kappaI O18/O8) forms a canonical dimer observed in other light chain crystal structures. In solution, conformational heterogeneity obscures all NMR signals at the AL-09 and kappaI O18/O8 dimer interfaces, so we solved the nuclear magnetic resonance structure of two related mutants. AL-09 H87Y adopts the normal dimer interface, but the kappaI Y87H solution structure presents an altered interface rotated 180 degrees relative to the canonical dimer interface and 90 degrees from the AL-09 arrangement. Our results suggest that promiscuity in the light chain dimer interface may promote new intermolecular contacts that may contribute to amyloid fibril structure.
Peterson
Francis C
FC
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Baden
Elizabeth M
EM
Owen
Barbara A L
BA
Volkman
Brian F
BF
Ramirez-Alvarado
Marina
M
D000682:Amyloid / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D000686:Amyloidosis / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D009154:Mutation; D057165:Proteostasis Deficiencies
D000682:Amyloid
Nat Chem Biol. 2009 Nov;5(11):789-96
19841628
J Biomol NMR. 1999 Mar;13(3):289-302
10212987
J Biomol NMR. 1996 May;7(3):207-13
22911044
J Biol Chem. 2002 Mar 1;277(9):7086-91
11751892
Biochemistry. 1999 Oct 19;38(42):14101-8
10529258
Semin Hematol. 1995 Jan;32(1):45-59
7878478
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9490-4
7568160
J Biol Chem. 2008 Nov 7;283(45):30950-6
18768467
Curr Protein Pept Sci. 2009 Oct;10(5):500-508
19538145
Anal Biochem. 2004 Mar 15;326(2):234-56
15003564
J Magn Reson. 2003 Jan;160(1):65-73
12565051
J Mol Biol. 2002 May 24;319(1):209-27
12051947
Eur J Biochem. 1999 Feb;260(1):192-9
10091599
Mayo Clin Proc. 1989 Dec;64(12):1505-19
2513459
Biochemistry. 1994 Dec 13;33(49):14848-57
7993911
Acta Crystallogr D Biol Crystallogr. 2002 May;58(Pt 5):815-23
11976493
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
Biophys Chem. 2006 Feb 1;119(3):271-81
16213082
Nat Struct Mol Biol. 2005 Aug;12(8):663-70
16025128
J Mol Biol. 2007 Sep 21;372(3):774-97
17681537
Clin Exp Immunol. 1999 Dec;118(3):344-8
10594550
Proteins. 2003 Feb 15;50(3):496-506
12557191
J Biomol NMR. 1995 Jul;6(1):1-10
22911575
Proc Natl Acad Sci U S A. 1985 Jul;82(14):4592-6
3927286
J Biol Chem. 2008 Jun 6;283(23):15853-60
18400753
Amyloid. 1999 Sep;6(3):165-71
10524280
Protein Sci. 2006 Jul;15(7):1710-22
16751605
Proc Natl Acad Sci U S A. 1980 Feb;77(2):1144-8
6767243
Biochemistry. 1975 Nov 4;14(22):4943-52
1182131
PLoS One. 2009;4(4):e5169
19365555
Protein Sci. 2002 May;11(5):1036-49
11967361
Biochem Biophys Res Commun. 1998 Oct 20;251(2):642-7
9792827